Nalaganje...
Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial
Current directions in medication development for alcohol use disorder (AUD) emphasize the need to identify novel molecular targets and efficiently screen new compounds aimed at those targets. Ibudilast (IBUD) is a neuroimmune modulator that inhibits phosphodiesterase-4 and -10 and macrophage migrati...
Shranjeno v:
| izdano v: | Neuropsychopharmacology |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520778/ https://ncbi.nlm.nih.gov/pubmed/28091532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2017.10 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|